Reovirus Treatment Activates Immune Responses in Melanoma Cells
Author Information
Author(s): Lynette Steele, Fiona Errington, Robin Prestwich, Elizabeth Ilett, Kevin Harrington, Hardev Pandha, Matt Coffey, Peter Selby, Richard Vile, Alan Melcher
Primary Institution: Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK
Hypothesis
Reovirus treatment of melanoma cells induces pro-inflammatory cytokine and chemokine production that supports anti-tumor immune responses.
Conclusion
Reovirus infection of melanoma cells activates immune responses that can recruit and activate both innate and adaptive immune cells.
Supporting Evidence
- Reovirus-infected melanoma cells secrete multiple pro-inflammatory chemokines.
- IL-8 and IFN-β secretion is dependent on NF-κB activation.
- Conditioned media from reovirus-treated cells induces chemotaxis in NK cells and dendritic cells.
- NK cells cultured in reovirus-conditioned media show increased activation markers.
- Reovirus treatment enhances the ability of dendritic cells to prime anti-tumor T cells.
Takeaway
When melanoma cells are treated with reovirus, they release signals that help the immune system fight the cancer, even after the virus is gone.
Methodology
The study involved treating melanoma cell lines with reovirus and analyzing the resulting cytokine and chemokine production, as well as the activation of immune cells.
Limitations
The study does not specify the exact chemokines responsible for immune cell migration.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website